Photomedicine Market Report 2026

Photomedicine Market Report 2026
Global Outlook – By Type (Light Emitting Diodes, Lasers, Full Spectrum Light, Polychromatic Polarized Light, Dichroic Lamps, Fluorescent Lamps), By Application (Oncology, Dermatology, Pain Management, Dental Procedures, Aesthetics, Ophthalmology, Other Applications), By End Users (Hospitals And Clinics, Dermatology And Ophthalmology Centers, Home-Based Therapy, Research And Academic Institutions) – Market Size, Trends, Strategies, and Forecast to 2035
Photomedicine Market Overview
• Photomedicine market size has reached to $4.95 billion in 2025 • Expected to grow to $7.62 billion in 2030 at a compound annual growth rate (CAGR) of 8.9% • Growth Driver: Rising Cosmetic Surgeries Fuel Growth In The Market Due To Growing Demand For Non-Invasive Aesthetic Enhancements • Market Trend: Development In Light-Emitting Diode (LED) Technology For Eczema Relief • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Photomedicine Market?
Photomedicine is a branch of medicine that applies light-based technologies to diagnose and treat a wide range of conditions. It utilizes specific wavelengths of light to trigger biological responses, eliminate harmful cells, and support tissue regeneration. Photomedicine uses non-invasive or minimally invasive methods to make treatments more precise, safer, and quicker to recover from. The main types of photomedicine are light-emitting diodes, lasers, full-spectrum light, polychromatic polarized light, dichroic lamps, and fluorescent lamps. A light-emitting diode (LED) is a gentle, non-invasive light source that emits targeted wavelengths to activate cellular processes and support therapeutic healing. It is applied in various applications, such as oncology, dermatology, pain management, dental procedures, aesthetics, ophthalmology, and others, and is utilized by several end users, including hospitals and clinics, dermatology and ophthalmology centers, home-based therapy setups, and research and academic institutions.
What Is The Photomedicine Market Size and Share 2026?
The photomedicine market size has grown strongly in recent years. It will grow from $4.95 billion in 2025 to $5.41 billion in 2026 at a compound annual growth rate (CAGR) of 9.3%. The growth in the historic period can be attributed to limited availability of photomedicine devices, reliance on conventional treatment methods, increasing prevalence of skin and dental conditions, growing hospital and clinic infrastructure, rising awareness about non-invasive therapies.What Is The Photomedicine Market Growth Forecast?
The photomedicine market size is expected to see strong growth in the next few years. It will grow to $7.62 billion in 2030 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to advancements in led and laser technologies, increasing integration of wearable photomedicine devices, expansion of home-based therapy solutions, growing research in tissue regeneration applications, rising adoption of digital monitoring and remote therapy platforms. Major trends in the forecast period include rising adoption of light-based therapies in oncology and dermatology, growth in home-based photomedicine devices and therapy systems, increasing use of non-invasive pain management solutions, expansion of aesthetic and cosmetic photomedicine treatments, integration of photomedicine in dental and ophthalmic procedures.Global Photomedicine Market Segmentation
1) By Type: Light Emitting Diodes, Lasers, Full Spectrum Light, Polychromatic Polarized Light, Dichroic Lamps, Fluorescent Lamps 2) By Application: Oncology, Dermatology, Pain Management, Dental Procedures, Aesthetics, Ophthalmology, Other Applications 3) By End Users: Hospitals And Clinics, Dermatology And Ophthalmology Centers, Home-Based Therapy, Research And Academic Institutions Subsegments: 1) By Light Emitting Diodes: Red Light Therapy, Blue Light Therapy, Infrared Light Emitting Diode Therapy 2) By Lasers: Low Level Laser Therapy (LLLT), High Intensity Laser Therapy (HILT), Pulsed Dye Lasers 3) By Full Spectrum Light: White Light Therapy, Bright Light Therapy, Seasonal Affective Disorder (SAD) Lamps 4) By Polychromatic Polarized Light: Bioptron Light Therapy, Polarized Multicolor Light Emitting Diode Systems 5) By Dichroic Lamps: Infrared Dichroic Lamps, Ultraviolet Dichroic Lamps, Visible Light Dichroic Lamps 6) By Fluorescent Lamps: Narrowband Ultraviolet B Lamps, Broadband Ultraviolet B Lamps, Ultraviolet A LampsWhat Is The Driver Of The Photomedicine Market?
The rising cosmetic surgeries are expected to propel the growth of the photomedicine market going forward. Cosmetic surgeries are medical procedures performed to improve or alter a person’s appearance for aesthetic purposes. The rise in cosmetic surgeries is due to increasing social media influence and the growing desire for enhanced self-image, fueled by widespread exposure to beauty standards and trends. Photomedicine is useful for cosmetic surgeries by enabling precise, non-invasive treatments that enhance skin appearance, reduce blemishes, and improve overall facial and body aesthetics with minimal downtime. For instance, in April 2025, according to the British Association of Aesthetic Plastic Surgeons (BAAPS), a UK-based surgical organization, 27,462 cosmetic surgical procedures were performed, marking a 5% increase compared to 2023. Therefore, the rising cosmetic surgeries is driving the growth of the photomedicine industry.Key Players In The Global Photomedicine Market
Major companies operating in the photomedicine market are BIOLASE Inc., Lumenis Ltd., Candela Medical Inc., Fotona d.o.o., IRIDEX Corporation, PhotoCure ASA, Clinuvel Pharmaceuticals Limited, Erchonia Lasers Limited, Biolitec biomedical technology GmbH, Lynton Lasers Limited, Aspen Laser Systems LLC, Carl Zeiss AG, LightStim LLC, PhotoMedex Inc., Quanta Systems Ltd., THOR Photomedicine LimitedGlobal Photomedicine Market Trends and Insights
Major companies operating in the photomedicine market are focusing on developing advanced products such as light-emitting diode (LED) devices to improve treatment effectiveness and address a wider range of medical and cosmetic conditions. Light-emitting diode (LED) devices are non-invasive technologies that deliver specific wavelengths of light to activate cellular processes and support tissue recovery while being widely applied in photomedicine for healing, pain management, skin rejuvenation, and various therapeutic purposes. For instance, in April 2024, Bestqool, a US-based company that provides red light therapy technology, launched a red-light therapy device designed for eczema relief. It uses advanced wavelengths to reduce itching, swelling, and inflammation, thereby promoting skin healing without side effects. This therapy offers a non-drug alternative that has shown promising clinical improvements in eczema symptoms.What Are Latest Mergers And Acquisitions In The Photomedicine Market?
In July 2023, Alma, an Israel-based company that provides energy-based medical and aesthetic solutions, acquired PhotonMed International Limited for $40 million. Through this acquisition, Alma aims to expand its presence in the aesthetic and medical device sector and enhance its portfolio with advanced, user-centric solutions for healthcare and beauty treatments. PhotonMed International Limited is a Hong Kong-based company that develops photonics technologies in medical device applications.Regional Insights
North America was the largest region in the photomedicine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Photomedicine Market?
The photomedicine market consists of revenues earned by entities providing services such as light-based diagnostics, skin rejuvenation, low-level light therapy, and photodynamic therapy. The market value includes the value of related goods sold by the service provider or included within the service offering. The photomedicine market also includes sales of intense pulsed light systems, optical sensors, and phototherapy systems. Values in this market are ‘factory gate’ values; that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Photomedicine Market Report 2026?
The photomedicine market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the photomedicine industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Photomedicine Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $5.41 billion |
| Revenue Forecast In 2035 | $7.62 billion |
| Growth Rate | CAGR of 9.3% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Type, Application, End Users |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | BIOLASE Inc., Lumenis Ltd., Candela Medical Inc., Fotona d.o.o., IRIDEX Corporation, PhotoCure ASA, Clinuvel Pharmaceuticals Limited, Erchonia Lasers Limited, Biolitec biomedical technology GmbH, Lynton Lasers Limited, Aspen Laser Systems LLC, Carl Zeiss AG, LightStim LLC, PhotoMedex Inc., Quanta Systems Ltd., THOR Photomedicine Limited |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
Frequently Asked Questions
The Photomedicine market was valued at $4.95 billion in 2025, increased to $5.41 billion in 2026, and is projected to reach $7.62 billion by 2030.
The global Photomedicine market is expected to grow at a CAGR of 8.9% from 2026 to 2035 to reach $7.62 billion by 2035.
Some Key Players in the Photomedicine market Include, BIOLASE Inc., Lumenis Ltd., Candela Medical Inc., Fotona d.o.o., IRIDEX Corporation, PhotoCure ASA, Clinuvel Pharmaceuticals Limited, Erchonia Lasers Limited, Biolitec biomedical technology GmbH, Lynton Lasers Limited, Aspen Laser Systems LLC, Carl Zeiss AG, LightStim LLC, PhotoMedex Inc., Quanta Systems Ltd., THOR Photomedicine Limited .
Major trend in this market includes: Development In Light-Emitting Diode (LED) Technology For Eczema Relief. For further insights on this market.
Request for SampleNorth America was the largest region in the photomedicine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the photomedicine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
